MolecuLight Inc. Ontario

is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X® and DX™ wound imaging devices. These are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications.

For sales, media or other inquiries or further information, please contact: Hunter Zudans, Director of Marketing, MolecuLight Inc., T. +1.484.682.7580, hzudans@moleculight.com, www.moleculight.com 

Photo - https://mma.prnewswire.com/media/2489714/MolecuLight_MolecuLight_Announces_Integration_with_Intellicure_E.jpg

View original content:https://www.prnewswire.co.uk/news-releases/moleculight-announces-integration-with-intellicure-electronic-health-record-ehr-for-seamless-data-and-image-transfer-302230983.html